NorthSea Therapeutics is based in Naarden, The Netherlands. It has raised $68M in total funding. Latest round: Series C.
NorthSea Therapeutics is based in Naarden, The Netherlands. NorthSea Therapeutics has raised $68M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2020. The round record for NorthSea Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include venBio Partners, Sofinnova Investments, Forbion, Novo Seeds, New Science Ventures, BioGeneration Ventures. 6 distinct backers are named across the disclosed rounds.
Every NorthSea Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Naarden at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026